BRD4‐IRF1 axis regulates chemoradiotherapy‐induced PD‐L1 expression and immune evasion in non‐small cell lung cancer

Jian Wang, Yingzhuo Xu, Xinrui Rao, +14

Clinical and Translational Medicine

NLRP6 is required for cancer-derived exosome-modified macrophage M2 polarization and promotes metastasis in small cell lung cancer

Xinrui Rao, Xiaoshu Zhou, Geng Wang, +10

Cell Death and Disease

Activation of NLRP3 inflammasome in lung epithelial cells triggers radiation-induced lung injury

Xinrui Rao, Dong Zhou, Huilin Deng, +15

Respiratory Research

PD-1+ mast cell enhanced by PD-1 blocking therapy associated with resistance to immunotherapy

Jun Li, Gang Peng, Kuikui Zhu, +8

Cancer Immunology Immunotherapy

REV1 promotes lung tumorigenesis by activating the Rad18/SERTAD2 axis

Yunshang Chen, Xiaohua Jie, Biyuan Xing, +10

Cell Death and Disease

Activated amino acid response pathway generates apatinib resistance by reprograming glutamine metabolism in non-small-cell lung cancer

Xiaoshu Zhou, Rui Zhou, Xinrui Rao, +8

Cell Death and Disease

The importance of overweight in COVID-19

Xinrui Rao, Chuangyan Wu, Sihua Wang, +4

Medicine

Targeting ADRB2 enhances sensitivity of non-small cell lung cancer to VEGFR2 tyrosine kinase inhibitors

Yingzhuo Xu, Jian Wang, Xu Wang, +9

Cell Death Discovery

Advanced NsclcAngiogenesisCell SignalingMedicineReceptor Tyrosine Kinase +13

Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma

Xinrui Rao, Biyuan Xing, Zilong Wu, +14

Cancer Science

Lung AdenocarcinomaPathologyMolecular BiologyDna Replication ProteinsCancer Biology +15

Targeting FBXO22 enhances radiosensitivity in non-small cell lung cancer by inhibiting the FOXM1/Rad51 axis

Yunshang Chen, Yun Zhou, Feng Xue, +10

Cell Death and Disease